28
May
2016
FDA approves first buprenorphine implant for treatment of opioid dependence
Posted On May 28, 2016
By Dr.Adel Serag
And has No Comment
Buprenorphine is a semisynthetic opioid derivative of thebaine. It is a mixed partial agonist opioid receptor modulator that is used to treat opioid addiction in higher dosages, to control moderate acute pain in non-opioid-tolerant individuals in lower dosages and to control moderate chronic pain in even […]
Read More
